Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: Revolution medicines - What They Never Told You

National Cancer Survivors Day Is Sunday — And for Dallas's Pancreatic Cancer Patients, There Has Never Been More Reason to Celebrate

National Cancer Survivors Day arrives with unprecedented hope for Dallas-Fort Worth pancreatic cancer patients as a breakthrough new drug nearly doubles survival in a landmark Phase 3 trial, marking a major advance against one of the deadliest cancers.

"Transformative Advance" in Cancer Treatment Emerges in Dallas — New Pill Shows Rare Survival Jump in Pancreatic Cancer Patients

"Transformative Advance" in Cancer Treatment Emerges in Dallas — New Pill Shows Rare Survival Jump in Pancreatic Cancer Patients

Pancreatic Cancer treatment may be entering a new era as a breakthrough pill nearly doubles survival in metastatic patients, offering new hope for one of the deadliest forms of cancer.

Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease

Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease

For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within five years of their diagnosis.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Revolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy?

Revolution Medicines stock rallies on impressive daraxonrasib Phase 3 results. Here’s why RVMD shares may sustain the momentum moving forward.

New cancer drug shows potential to double patients’ survival time

The Independent UK

New pancreatic cancer drug nearly doubles survival time in patients

Pancreatic cancer is the only cancer with a five-year survival rate that’s below 20%

The Independent UK

This Oncology Stock Just Hit New All-Time Highs

Revolution Medicines (RVMD) is trading at fresh all-time highs. RVMD exhibits strong technical momentum with a 100% technical “Buy” opinion from Barchart. Shares are up nearly 60% over the past year. Wall Street analysts are overwhelmingly bullish on RVMD, although sentiment is mixed across other platforms. Today’s Featured Stock Valued...

inkl

Read news from The Economist, FT, and more,
with one subscription

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Friday.

Analysts Raise Price Targets Following Strong Data From Revolution Medicines' Pancreatic Cancer Drug

Analysts Raise Price Targets Following Strong Data From Revolution Medicines' Pancreatic Cancer Drug

Revolution Medicines, Inc. (NASDAQ:RVMD) stock is trading higher after the company shared updates from its Daraxonrasib Phase 1 trials on Wednesday.

Revolution Medicines's Return On Capital Employed Overview

Revolution Medicines's Return On Capital Employed Overview

Revolution Medicines (NASDAQ:RVMD) brought in sales totaling $7.58 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 9.44%, resulting in a loss of $57.65 million.

Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022

Revolution Medicines's Earnings Outlook

Revolution Medicines's Earnings Outlook

Revolution Medicines (NASDAQ:RVMD) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Revolution Medicines will report an earnings per share (EPS) of $-0.77.

Children's Place And 2 Other Stocks Bought By Insiders

Children's Place And 2 Other Stocks Bought By Insiders

Although US stock futures traded higher this morning on Friday, there were a few notable insider trades.

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

B of A Securities

the American Cancer Society

Hewlett Packard

Ollie Bargain Outlet

UT Southwestern

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

384,512 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play